Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion

0
0
Loading ....

Johnson & Johnson claimed Wednesday it accepted purchase drugmaker Momenta Pharmaceuticals Inc. for around $6.5 billion, providing J&J access right into a possibly big-selling brand-new course of medicines to deal with ce …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here